Table 2:

Comparison of the DCE pharmacokinetic parameters of patients with true progression versus pseudoprogression

Pharmacokinetic ParameterT1 MethodTrue Progression (n = 15)Pseudoprogression (n = 22)P ValueaIntraclass Correlation Coefficient [95% CI]
Mean ± SDMedian [range]Mean ± SDMedian [range]IntraobserverInterobserver
Ktrans, min−1Fixed0.138 ± 0.1480.096 [0.042–0.579]0.068 ± 0.0430.064 [0.0005–0.154].05b0.893 [0.792–0.945]0.897 [0.799–0.947]
Measured0.126 ± 0.1390.069 [0.025–0.499]0.056 ± 0.0450.058 [0.0001–0.194].100.923 [0.850–0.960]0.943 [0.888–0.970]
Kep, min−1Fixed0.321 ± 0.2440.244 [0.135–1.082]0.179 ± 0.1030.179 [0.024–0.483].01b0.910 [0.825–0.954]0.929 [0.862–0.963]
Measured0.224 ± 0.1080.202 [0.035–0.396]0.192 ± 0.1480.157 [0.009–0.494].470.861 [0.729–0.928]0.882 [0.771–0.939]
Vp, %Fixed3.309 ± 4.4291.468 [0.709–18.298]1.998 ± 1.4621.705 [0.140–6.723].600.872 [0.752–0.934]0.888 [0.784–0.943]
Measured2.358 ± 2.7011.339 [0.478–10.407]1.521 ± 1.4561.134 [0.081–6.056].270.800 [0.605–0.895]0.688 [0.394–0.839]
VeFixed0.536 ± 0.3300.446 [0.168–1.050]0.506 ± 0.2840.482 [0.114–1.156].770.761 [0.537–0.877]0.718 [0.516–0.844]
Measured0.550 ± 0.5110.377 [0.121–1.192]0.316 ± 0.2650.270 [0.041–1.297].080.937 [0.877–0.968]0.936 [0.875–0.967]
  • a P values are from Student t test when the variables satisfied normality (Kep from measured T1 and Ve from fixed T1) or from Mann-Whitney U tests otherwise, according to Kolmogorov-Smirnov test.

  • b Significant P value for each test.